Phathom Pharmaceuticals Inc. (PHAT)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 2,274,157 $18,466,155 +52% 9.39%
2.
Avidity Partners Management

David Witzke And Michael Gregory

1,390,100 $11,287,612 -23% 1.1%
3. 1,025,000 $8,323,001 +2% 0.51%
4.
Woodline Partners

Michael Rockefeller And Karl Kroeker

1,001,692 $8,133,739 -62% 0.05%
5.
Propel Bio Management

Leen Kawas And Richard Kayne

989,927 $8,038,207 +14% 7.98%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.93 12,500 57,000 2024-12-13 Filing
$8.12 10,000 75,500 2024-12-13 Filing
$7.80 2,500 Director 55,000 2023-11-08 Filing
$7.76 4,000 Director 52,500 2023-11-07 Filing
$8.04 1,000 Director 48,500 2023-11-06 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.59 6,583 93,546 2025-01-21 Filing
$6.59 7,886 233,390 2025-01-21 Filing
$6.59 19,109 360,465 2025-01-21 Filing
$8.00 1,118 239,303 2024-12-19 Filing
$8.00 1,291 98,156 2024-12-19 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 10,109,279 $82,087,345 3.4%
2. 7,464,572 $60,612,325 11.45%
3. 7,062,507 $57,347,554 0.03%
4. 3,671,386 $29,811,654 0%
5. 3,502,375 $28,439,286 0%
News See All